Last Updated : July 8, 2004
Details
Generic Name:
Eprosartan mesylate/ hydrochlorothiazide
Project Status:
Complete
Therapeutic Area:
Hypertension, Essential
Manufacturer:
Solvay Pharma Inc.
Brand Name:
Teveten Plus
Project Line:
Reimbursement Review
Project Number:
SR0016-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Hypertension, Essential
Recommendation Type:
List in a similar manner to other drugs in class
Final Recommendation:
Recommendation:
List in a similar manner as other ARB/HCTZ combination products.
Last Updated : July 8, 2004